Trade Names: | |
Synonyms: | |
Status: | Approved (1960) |
Entry Type: | Small molecule |
Molecule Category: | Parent |
ATC: | C02AA02 |
UNII: | 8B1QWR724A |
InChI Key | QEVHRUUCFGRFIF-MDEJGZGSSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C33H40N2O9 |
Molecular Weight | 608.69 |
AlogP | 4.17 |
Hydrogen Bond Acceptor | 10.0 |
Hydrogen Bond Donor | 1.0 |
Number of Rotational Bond | 8.0 |
Polar Surface Area | 117.78 |
Molecular species | NEUTRAL |
Aromatic Rings | 3.0 |
Heavy Atoms | 44.0 |
Primary Target | |
---|---|
Vesicular monoamine transporter 2 |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Enzyme
Hydrolase
|
- | - | - | - | 15 | |
Ion channel
Voltage-gated ion channel
Voltage-gated sodium channel
|
- | 1600 | - | - | 100 | |
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC18 family of vesicular amine transporters
|
- | 13 | 8 | 5-630 | - | |
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 25 | |
Transporter
Electrochemical transporter
|
- | 7000-9200 | 8 | 5-630 | 30-85 | |
Transporter
Primary active transporter
ATP-binding cassette
ABCB subfamily
|
- | 3020-3236 | - | 100 | - | |
Transporter
Primary active transporter
ATP-binding cassette
ABCC subfamily
|
- | 68400 | - | - | - | |
Transporter
Primary active transporter
ATP-binding cassette
ABCG subfamily
|
- | 12600-26303 | - | - | - |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Diabetes Mellitus, Type 2 | 3 | D003924 | ClinicalTrials |
Atherosclerosis | 3 | D050197 | ClinicalTrials |
Hypercholesterolemia | 3 | D006937 | ClinicalTrials |
Coronary Disease | 3 | D003327 | ClinicalTrials |
Cerebrovascular Disorders | 3 | D002561 | ClinicalTrials |
Heart Diseases | 3 | D006331 | ClinicalTrials |
Cocaine-Related Disorders | 2 | D019970 | ClinicalTrials |
Hypertension, Pulmonary | 1 | D006976 | ClinicalTrials |
Amphetamine-Related Disorders | 1 | D019969 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 50-55-5 |
ChEBI | 28487 |
ChEMBL | CHEMBL772 |
DrugBank | DB00206 |
DrugCentral | 2370 |
EPA CompTox | DTXSID7021237 |
FDA SRS | 8B1QWR724A |
Human Metabolome Database | HMDB0014351 |
Guide to Pharmacology | 4823 |
KEGG | C06539 |
PharmGKB | PA451236 |
PubChem | 5770 |
SureChEMBL | SCHEMBL2589 |
ZINC | ZINC000003938746 |